Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3068944 | 0.89 | RAB9A (0.45) | KMT2AALDH1A1GAATSHRKCNA5 | |
| SCHEMBL3071313 | 0.88 | CYP19A1 (0.44) | KMT2AALDH1A1KCNA5SMN1; SMN2KDM4E | |
| SCHEMBL3075817 | 0.80 | ALOX15 (0.48) | KMT2AALDH1A1NPSR1KCNA5SMN1; SMN2 | |
| SCHEMBL3074237 | 0.78 | SMN1; SMN2 (0.43) | ALDH1A1KCNA5SMN1; SMN2KDM4ERAB9A | |
| SCHEMBL6310768 | 0.78 | NPY5R (0.49) | ALDH1A1KCNA5SMN1; SMN2RAB9A | |
| SCHEMBL3074125 | 0.78 | SMN1; SMN2 (0.43) | ALDH1A1KCNA5SMN1; SMN2KDM4ETBXAS1 | |
| SCHEMBL3079297 | 0.77 | KCNA5 (0.46) | KMT2ATSHRKCNA5TBXAS1 | |
| SCHEMBL3062323 | 0.77 | KMT2A (0.60) | KMT2AALDH1A1GAATSHRNPSR1 | |
| SCHEMBL6505819 | 0.76 | SMN1; SMN2 (0.58) | ALDH1A1GAAKCNA5SMN1; SMN2KDM4E | |
| SCHEMBL3075124 | 0.76 | TSHR (0.49) | ALDH1A1GAATSHRNPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100267555-A1 | Fungicidal mixtures II | BASF SE (DE) | 2010-10-21 | — | — | US | claimed |
| EP-2222169-A2 | FUNGICIDAL MIXTURES II | BASF SE (DE) | 2010-09-01 | — | — | EP | claimed |
| WO-2009063075-A2 | FUNGICIDAL MIXTURES II | BASF SE (DE) | 2009-05-22 | — | — | WO | claimed |
| US-20100267555-A1 | Fungicidal mixtures II | BASF SE (DE) | 2010-10-21 | — | — | US | disclosed |
| EP-2222169-A2 | FUNGICIDAL MIXTURES II | BASF SE (DE) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009063075-A2 | FUNGICIDAL MIXTURES II | BASF SE (DE) | 2009-05-22 | — | — | WO | disclosed |
| US-20050277663-A1 | 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides | ATP CAPITAL LP | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277663-A1 | 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides | CYP21A2, HAO1, AHR | KMT2A 1213/4885ALDH1A1 99/4885GAA 1736/4885 |
| US-20100267555-A1 | Fungicidal mixtures II | CBR3, CBR1, NOX3 | KMT2A 4299/4885ALDH1A1 764/4885GAA 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.